New protocols & dosing updates Reconstitution charts, new peptide protocols and safety updates straight to your inbox
A pivotal 2021 clinical study of more than 1,900 adults, known as the STEP 1 trial, laid the groundwork for the use of these drugs as a treatment for weight loss
While some telehealth providers may still offer compounded versions under different names or vague custom protocols, these formulations are not FDA-approved, lack clinical testing and can expose patients to unknown health risks
GLP-1 innovation vector (2): Expanded indications One of the biggest differentiators in the next few years will be how far GLP-1s can extend beyond diabetes and obesity
There are these kind of outrageous claims about people recovering from complete tissue transections
Table 12: Results at Week 24 (LOCF*) in an Active-Controlled Trial of Dapagliflozin Initial Combination Therapy with Metformin HCl Extended-Release in Adults with Type 2 Diabetes Mellitus Dapagliflozin Add-On To Metformin HCl Immediate-Release A total of 546 adult patients with type 2 diabetes mellitus with inadequate glycemic control (HbA1c 7% and 10%) participated in a 24-week, placebo-controlled trial to evaluate dapagliflozin in combination with metformin HCl (NCT00528879)